Belpointe Asset Management LLC Natera, Inc. Transaction History

Belpointe Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$36.57 - $58.29 $32,474 - $51,761	888 Added 127.22%	1,586 $88,000
Q4 2022 Feb 08, 2023	BUY	$34.17 - $47.91 $23,850 - $33,441	698 New	698 $28,000
Q1 2022 Apr 28, 2022	SELL	$30.32 - $91.33 $33,564 - $101,102	-1,107 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$86.26 - $119.0 $23,203 - $32,011	-269 Reduced 19.55%	1,107 $104,000
Q3 2021 Nov 15, 2021	BUY	$100.17 - $126.36 $47,180 - $59,515	471 Added 52.04%	1,376 $154,000
Q2 2021 Aug 09, 2021	BUY	$86.05 - $119.72 $77,875 - $108,346	905 New	905 $104,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Belpointe Asset Management LLC with notifications on news.